The efficacy and tolerability of pomalidomide in relapsed/refractory myeloma patients in a "real-world" study: the Royal Marsden Hospital experience

MeSH terms

• Angiogenesis Inhibitors / administration & dosage
• Angiogenesis Inhibitors / adverse effects
• Angiogenesis Inhibitors / therapeutic use*
• Antineoplastic Agents / administration & dosage
• Antineoplastic Agents / adverse effects
• Antineoplastic Agents / therapeutic use*
• Combined Modality Therapy
• Drug Resistance, Neoplasm
• Follow-Up Studies
• Humans
• Kaplan-Meier Estimate
• Multiple Myeloma / diagnosis
• Multiple Myeloma / drug therapy*
• Multiple Myeloma / mortality
• Neoplasm Grading
• Neoplasm Staging
• Recurrence
• Retreatment
• Thalidomide / administration & dosage
• Thalidomide / adverse effects
• Thalidomide / analogs & derivatives*
• Thalidomide / therapeutic use
• Treatment Outcome